The use of rituximab therapy in patients with acquired factor V inhibitors

Am J Hematol. 2012 Aug;87(8):826-7. doi: 10.1002/ajh.23241. Epub 2012 May 28.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Animals
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Blood Coagulation Factor Inhibitors / blood*
  • Cattle
  • Factor V*
  • Female
  • Follow-Up Studies
  • Hemorrhage / blood*
  • Hemorrhage / chemically induced
  • Hemorrhage / drug therapy*
  • Hemostatics / administration & dosage
  • Hemostatics / adverse effects
  • Humans
  • Rituximab
  • Thrombin / administration & dosage
  • Thrombin / adverse effects

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Blood Coagulation Factor Inhibitors
  • Hemostatics
  • Rituximab
  • Factor V
  • Thrombin